CarMax stock falls more than 10% as CEO steps down, releases new outlook

CarMax stock falls more than 10% as CEO steps down, releases new outlook


A CarMax dealership in Santa Rosa, California, on April 11, 2023.

Justin Sullivan | Getty Images

DETROIT – Shares of CarMax Inc. fell more than 10% during premarket trading Thursday after the used car retailer announced a weak preliminary outlook for its current fiscal quarter and said CEO Bill Nash would be unexpectedly stepping down.

The preliminary outlook for its third fiscal quarter includes an 8% to 12% decrease in comparable store used unit sales and net earnings per diluted share of between 18 cents and 36 cents, including 9 cents in non-recurring expenses related primarily to the leadership shakeup and other workforce reductions.

Regarding its CEO, the company said board member David McCreight, a retail clothing executive who has served as CEO of Lulu’s Fashion Lounge Holdings and president of Urban Outfitters Inc., will replace Nash on an interim basis until a permanent replacement has been found.

CarMax also said Chair Tom Folliard, an executive with a 30-year history with the company, including as CEO from 2006 to 2016, has been appointed interim executive chair.

“The Board has decided that more direct involvement from David and me will help strengthen the business in this transitional period. During this time, we are focused on driving sales, enhancing profitability and reducing cost,” Folliard said in a release, adding that the company’s recent results “do not reflect that potential and change is needed.”

Stock Chart IconStock chart icon

hide content

Auto dealer stocks

The announced changes are effective Dec. 1, according to CarMax.

In connection to the announced changes and outlook, William Blair downgraded CarMax stock to market perform from outperform.

CarMax has struggled this year, with its stock price down roughly 50% in 2025. That compares with other car retailer stocks being up double digits, including a 52% increase this year for online used car retailer Carvana.

Nash on CarMax’s most recent quarterly earnings call in September admitted that results that “fell short” of the company’s expectations, as well as Wall Street’s. The results included notable declines in nearly all key earnings including sales, net earnings and gross profit.

Those September results led to a significant decline in shares of the company and negative analyst reactions, including a $24 price cut by Morgan Stanley.

CarMax is scheduled to report its current fiscal quarter results on Dec. 18.



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More